Adverse events2,172

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 2,172

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) - Alpelisib Arm	0	54
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) - Placebo Arm	0	27
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) Alpelisib Period/Alpelisib Arm	0	54
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) Alpelisib Period/Placebo Arm	0	26
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) All Adults in Alpelisib Period	0	80
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 2 (6-17 Years) - Alpelisib Arm	0	56
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 2 (6-17 Years) - Placebo Arm	0	28
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 2 (6-17 Years) Alpelisib Period Alpelisib Arm	0	56
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 2 (6-17 Years) Alpelisib Period Placebo Arm	0	26
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 2 (6-17 Years) All Pediatrics in Alpelisib Period	0	82
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 4 (2-5 Years) All Pediatrics	1	7
other	Abdominal lymphadenopathy	Blood and lymphatic system disorders	Group 5 (6-17 Years) All Pediatrics	0	16
other	Leukocytosis	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) - Alpelisib Arm	0	54
other	Leukocytosis	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) - Placebo Arm	0	27
other	Leukocytosis	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) Alpelisib Period/Alpelisib Arm	0	54
other	Leukocytosis	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) Alpelisib Period/Placebo Arm	1	26
other	Leukocytosis	Blood and lymphatic system disorders	Group 1 (Greater or Equal to 18 Years) All Adults in Alpelisib Period	1	80
other	Leukocytosis	Blood and lymphatic system disorders	Group 2 (6-17 Years) - Alpelisib Arm	0	56
other	Leukocytosis	Blood and lymphatic system disorders	Group 2 (6-17 Years) - Placebo Arm	0	28
other	Leukocytosis	Blood and lymphatic system disorders	Group 2 (6-17 Years) Alpelisib Period Alpelisib Arm	0	56

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04589650/events

API reference For AI assistants

Adverse events2,172

Sources 3

Read this list from software.